{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:47:59Z","timestamp":1790099279518,"version":"4.0.1"},"reference-count":114,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100004421","name":"Warsaw University of Technology, Faculty of Chemistry","doi-asserted-by":"publisher","award":["9EM-5N\/2016"],"award-info":[{"award-number":["9EM-5N\/2016"]}],"id":[{"id":"10.13039\/501100004421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004421","name":"Warsaw University of Technology, Faculty of Chemistry","doi-asserted-by":"publisher","award":["10\/EM 1\/2017"],"award-info":[{"award-number":["10\/EM 1\/2017"]}],"id":[{"id":"10.13039\/501100004421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004421","name":"Warsaw University of Technology, Faculty of Chemistry","doi-asserted-by":"publisher","award":["11\/EM\/2018"],"award-info":[{"award-number":["11\/EM\/2018"]}],"id":[{"id":"10.13039\/501100004421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2018,12,6]]},"abstract":"<jats:sec><jats:title\/><jats:p>Since candidiasis is so difficult to eradicate with an antifungal treatment and the existing antimycotics display many limitations, hopefully new sulfone derivatives may overcome these deficiencies. It is pertinent to study new strategies such as sulfone derivatives targeting the virulence attributes of C. albicans that differentiate them from the host. During infections, the pathogenic potential of C. albicans relies on the virulence factors as follows: hydrolytic enzymes, transcriptional factors, adhesion, and development of biofilms. In the article we explored how the above-presented C. albicans fitness and virulence attributes provided a robust response to the environmental stress exerted by sulfones upon C. albicans; C. albicans fitness and virulence attributes are fungal properties whose inactivation attenuates virulence. Our understanding of how these mechanisms and factors are inhibited by sulfones has increased over the last years. As lack of toxicity is a prerequisite for medical approaches, sulfones (non-toxic as assessed in vitro and in vivo) may prove to be useful for reducing C. albicans pathogenesis in humans. The antifungal activity of sulfones dealing with these multiple virulence factors and fitness attributes is discussed.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389557518666180924121209","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T03:40:54Z","timestamp":1538106054000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Novel Sulfones with Antifungal Properties: Antifungal Activities and Interactions with Candida spp. Virulence Factors"],"prefix":"10.2174","volume":"19","author":[{"given":"Ma\u0142gorzata","family":"Gizi\u0144ska","sequence":"first","affiliation":[{"name":"National Institute of Public Health-National Institute of Hygiene, Chocimska 24, 00-791 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Staniszewska","sequence":"additional","affiliation":[{"name":"National Institute of Public Health-National Institute of Hygiene, Chocimska 24, 00-791 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Ochal","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","volume":"48","author":"Pfaller M.A.","year":"2010","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA. J Clin Microbiol, Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: A 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.,Global Antifungal Surveillance Group, 2010, 48,, 1366-1377,","journal-title":"J Clin Microbiol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","volume":"36","author":"Pfaller M.A.","year":"2010","unstructured":"Pfaller MA, Diekema DJ. Crit Rev Microbiol, Epidemiology of invasive mycoses in North America.,, 2010, 36,, 1-53,","journal-title":"Crit Rev Microbiol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"Brown G.D.","year":"2012","unstructured":"Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Sci Transl Med, Hidden killers: human fungal infections.,, 2012, 4,, 165rv13-,","journal-title":"Sci Transl Med"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/jac\/dkv445","volume":"71","author":"Ko\u0142aczkowska A.","year":"2016","unstructured":"Ko\u0142aczkowska A, Ko\u0142aczkowski M. J Antimicrob Chemother, Drug resistance mechanisms and their regulation in non-albicans Candida species.,, 2016, 71,, 1438-1450,","journal-title":"J Antimicrob Chemother"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"Pappas P.G.","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ. Clin Infect Dis, Clinical practicce guideline for the management of candidiasis: 2016 update by the Infectious Disease Society of America.,, 2016, 62,, e1-e50,","journal-title":"Clin Infect Dis"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"e59373","DOI":"10.1371\/journal.pone.0059373","volume":"8","author":"Nucci M.","year":"2013","unstructured":"Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, Guzman-Blanco M, Santolaya ME, Thompson L, Sifuentes-Osornio J. PLoS One, Epidemiology of candidemia in Latin America: a laboratory-based survey.,, 2013, 8,, e59373-,","journal-title":"PLoS One"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","volume":"10","author":"Yapar N.","year":"2014","unstructured":"Yapar N. Ther Clin Risk Manag, Epidemiology and risk factors for invasive candidiasis.,, 2014, 10,, 95-105,","journal-title":"Ther Clin Risk Manag"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/jac\/dkw091","volume":"71","author":"Govender N.P.","year":"2016","unstructured":"Govender NP, Patel J, Magobo RE, Naicker S, Wadula J, Whitelaw A, Coovadia Y, Kalaratne R, Govind C, Lockhart SR. J Antimicrob Chemother, Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: Results from laboratory-based sentinel surveillance in South Africa.,, 2016, 71,, 1994-2004,","journal-title":"J Antimicrob Chemother"},{"key":"ref=9","first-page":"CD004920","volume":"1","author":"Cortegiani A.","year":"2016","unstructured":"Cortegiani A, Russotto V, Maggiore A, Attanasio M, Naro AR, Raineri SM, Giarratano A. Cochrane Database Syst Rev, Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.,, 2016, 1,, CD004920-,","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00277-016-2630-1","volume":"95","author":"Hahn-Ast C.","year":"2016","unstructured":"Hahn-Ast C, Felder L, Mayer K, M\u00fcckter S, Ruhnke M, Hein R, Hellmich M, Schwab K, Rachow T, Brossart P, von Lilienfeld-Toal M. Ann Hematol, Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia.,, 2016, 95,, 1001-1009,","journal-title":"Ann Hematol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"w14281","DOI":"10.4414\/smw.2016.14281","volume":"146","author":"Schmiedel Y.","year":"2016","unstructured":"Schmiedel Y, Zimmerli S. Swiss Med Wkly, Common invasive fungal diseases: An overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.,, 2016, 146,, w14281-,","journal-title":"Swiss Med Wkly"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","volume":"45","author":"Silveira F.P.","year":"2007","unstructured":"Silveira FP, Husain S. Med Mycol, Fungal infections in solid organ transplantation.,, 2007, 45,, 305-320,","journal-title":"Med Mycol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.1080\/13693780500051984","volume":"43","author":"Singh N.","year":"2005","unstructured":"Singh N. Med Mycol, Invasive aspergillosis in organ transplant recipients: New issues in epidemiologic characteristics, diagnosis, and management.,, 2005, 43,, S267-S270,","journal-title":"Med Mycol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","volume":"18","author":"Singh N.","year":"2005","unstructured":"Singh N, Peterson DL. Clin Microbiol Rev, Aspergilus infections in transplant recipients.,, 2005, 18,, 44-69,","journal-title":"Clin Microbiol Rev"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-0691.2005.01128.x","volume":"11","author":"Sol\u00e9 A.","year":"2005","unstructured":"Sol\u00e9 A, Morant P, Salavert M, Pem\u00e1n J, Morales P. Clin Microbiol Infect, Aspergillus infections in lung transplant recipients: risk factors and outcome.,Valencia Lung Transplant Group, 2005, 11,, 359-365,","journal-title":"Clin Microbiol Infect"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trre.2007.12.007","volume":"22","author":"Sol\u00e9 A.","year":"2008","unstructured":"Sol\u00e9 A, Salavert M. Transplant Rev, Fungal infection after lung transplantation.,, 2008, 22,, 89-104,","journal-title":"Transplant Rev"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","volume":"195","author":"Singh N.","year":"2007","unstructured":"Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V. J Infect Dis, Mu oz, P.; Limaye, A.P.; Kalil, A.C.; Pruett, T.L.; Garcia-Diaz, J.; Humar, A.; Houston, S.; House, A.A.; Wray, D.; Orloff, S.; Dowdy, L.A.; Fisher, R.A.; Heitman, J.; Wagener, M.M.; Husain, S. Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality.,, 2007, 195,, 756-764,","journal-title":"J Infect Dis"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.qco.0000185984.57135.ad","volume":"18","author":"van Burik J.A.","year":"2005","unstructured":"van Burik JA. Curr Opin Infect Dis, Role of new antifungal agents in prphylaxis of mycoses in high risk patients.,, 2005, 18,, 479-483,","journal-title":"Curr Opin Infect Dis"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jinf.2007.06.012","volume":"55","author":"Metcalf S.C.","year":"2007","unstructured":"Metcalf SC, Dockrell DH. J Infect, Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.,, 2007, 55,, 287-299,","journal-title":"J Infect"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2147\/TCRM.S3994","volume":"4","author":"Zaragoza R.","year":"2008","unstructured":"Zaragoza R, Pem\u00e1n J, Salavert M, Viudes \u00c1, Sol\u00e9 A, Jarque I, Monte E, Rom\u00e1 E, Cant\u00f3n E. Ther Clin Risk Manag, Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?,, 2008, 4,, 1261-1280,","journal-title":"Ther Clin Risk Manag"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"e0158126","DOI":"10.1371\/journal.pone.0158126","volume":"11","author":"Peron I.H.","year":"2016","unstructured":"Peron IH, Reichert-Lima F, Busso-Lopes AF, Nagasako CK, Lyra L, Moretti ML, Schreiber AZ. PLoS One, Resistance surveillance in Candida albicans: a five-year antifungal susceptibility evaluation in a brazilian University Hospital.,, 2016, 11,, e0158126-,","journal-title":"PLoS One"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1749-6632.1988.tb40411.x","volume":"544","author":"Fasoli M.","year":"1988","unstructured":"Fasoli M, Kerridge D. Ann N Y Acad Sci, Isolation and characterization of fluoropyrimidine-resistant mutants in two Candida species.,, 1988, 544,, 260-263,","journal-title":"Ann N Y Acad Sci"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jac\/45.3.408","volume":"45","author":"Barchiesi F.","year":"2000","unstructured":"Barchiesi F, Arzeni D, Caselli F, Scalise G. J Antimicrob Chemother, Primary resistance to flucytosine among clinical isolates of Candida spp.,, 2000, 45,, 408-409,","journal-title":"J Antimicrob Chemother"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/AAC.46.11.3518-3521.2002","volume":"46","author":"Pfaller M.A.","year":"2002","unstructured":"Pfaller MA, Messer SA, Boyken L, Huynh H, Hollis RJ, Diakema DJ. Antimicrob Agents Chemother, In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: Global assessment of primary resistance using national committee for Clinical Laboratory Standards susceptibility testing methods.,, 2002, 46,, 3518-3521,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/AAC.48.1.262-266.2004","volume":"48","author":"Pujol C.","year":"2004","unstructured":"Pujol C, Pfaller MA, Soll DR. Antimicrob Agents Chemother, Flucytosine resistance is restricted to a single genetic clade of Candida albicans.,, 2004, 48,, 262-266,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/AAC.48.11.4377-4386.2004","volume":"48","author":"Hope W.W.","year":"2004","unstructured":"Hope WW, Tabernero L, Denning DW, Anderson MJ. Antimicrob Agents Chemother, Molecular mechanisms of primary resistance to flucytosine in Candida albicans.,, 2004, 48,, 4377-4386,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.48.6.2223-2227.2004","volume":"48","author":"Dodgson A.R.","year":"2004","unstructured":"Dodgson AR, Dodgson KJ, Pujol C, Pfaller MA, Soll DR. Antimicrob Agents Chemother, Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.,, 2004, 48,, 2223-2227,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jac\/dks481","volume":"68","author":"Jiang C.","year":"2013","unstructured":"Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, Peng Y. J Antimicrob Chemother, Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China.,, 2013, 68,, 778-785,","journal-title":"J Antimicrob Chemother"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fmed.2016.00011","volume":"3","author":"Sanglard D.","year":"2016","unstructured":"Sanglard D. Front Med, Emerging threats in antifungal-resistant fungal pathogens.,, 2016, 3,, 11-,","journal-title":"Front Med"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","volume":"50","author":"Pfaller M.A.","year":"2012","unstructured":"Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. J Clin Microbiol, Frequency of decreased susceptibility and resistance to chinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.,, 2012, 50,, 1199-1203,","journal-title":"J Clin Microbiol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","volume":"56","author":"Alexander B.D.","year":"2013","unstructured":"Alexander BD, Johnson MD, Pfeiffer CD, Jim\u00e9nez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. Clin Infect Dis, Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.,, 2013, 56,, 1724-1732,","journal-title":"Clin Infect Dis"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","volume":"57","author":"Forastiero A.","year":"2013","unstructured":"Forastiero A, Mesa-Arango AC, Alastruey-Izquierdo A, Alcazar-Fouli A, Bernal-Martinez L, Pelaez T, Lopez JF, Grimalt JO, Gomez-Lopez A, Cuesta I, Zaragoza O, Mellado E. Antimicrob Agents Chemother, Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.,, 2013, 57,, 4769-4781,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/ph6081055","volume":"6","author":"Aoki W.","year":"2013","unstructured":"Aoki W, Ueda M. Pharmaceuticals, Characterization of antimicrobial peptides toward the development of novel antibiotics.,, 2013, 6,, 1055-1081,","journal-title":"Pharmaceuticals"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/13543776.2014.876993","volume":"24","author":"Castelli M.V.","year":"2014","unstructured":"Castelli MV, Butassi E, Monteiro MC, Svetaz LA, Vicente F, Zacchino SA. Expert Opin Ther Pat, Novel antifungal agents: A patent review (2011-present).,, 2014, 24,, 323-338,","journal-title":"Expert Opin Ther Pat"},{"key":"ref=35","first-page":"19","volume":"7","author":"Ahmad I.","year":"2015","unstructured":"Ahmad I. Int J Pharma Sci, Shagufta. Sulfones: an important class of organic compounds with diverse biological activities.,, 2015, 7,, 19-27,","journal-title":"Int J Pharma Sci"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2174\/1568026615666150915111741","volume":"16","author":"Feng M.","year":"2016","unstructured":"Feng M, Tang B, Liang SH, Jiang X. Curr Top Med Chem, Sulfur containing scaffolds in drugs: Synthesis and application in medicinal chemistry.,, 2016, 16,, 1200-1216,","journal-title":"Curr Top Med Chem"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10876-015-0936-0","volume":"27","author":"Haddadi H.","year":"2016","unstructured":"Haddadi H, Farsani MR. J Cluster Sci, Selective oxidation of sulfides to sulfones by HO catalyzed by Fe-substituted sandwich type polyoxometalate.,, 2016, 27,, 373-386,","journal-title":"J Cluster Sci"},{"key":"ref=38","author":"Mac Bean C.","unstructured":"Mac Bean C, , Hampshire: British Crop Ptoduction Council,, , 16th ed, The Pesticide Manual: A World Compedium., 2013,-","journal-title":"The Pesticide Manual: A World Compedium"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1039\/C3SC52332B","volume":"5","author":"Richards-Taylor C.S.","year":"2014","unstructured":"Richards-Taylor CS, Blankemore DC, Willis MC. Chem Sci, One-pot three-component sulfone synthesis exploiting palladium-catalysed aryl halide aminosulfonylation.,, 2014, 5,, 222-228,","journal-title":"Chem Sci"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/1385272819666151014224211","volume":"20","author":"Borys K.M.","year":"2016","unstructured":"Borys KM, Ochal Z. Curr Org Chem, Synthetic approaches to aryl halomethyl sulfones.,, 2016, 20,, 963-970,","journal-title":"Curr Org Chem"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/S0040-4039(00)73291-6","volume":"35","author":"Su W.","year":"1994","unstructured":"Su W. Tetrahedron Lett, An efficient method for the oxidation of sulfides to sulfones.,, 1994, 35,, 4955-4958,","journal-title":"Tetrahedron Lett"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/S0040-4020(01)00068-0","volume":"57","author":"Sato K.","year":"2001","unstructured":"Sato K, Hyodo M, Aoki M, Zheng XQ, Noyori R. Tetrahedron, Oxidation of sulfides to sulfoxides and slufones with 30% hydrogen peroxide under organic solvent and halogen-free conditions.,, 2001, 57,, 2469-2476,","journal-title":"Tetrahedron"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/ol047635d","volume":"17","author":"Karimi B.","year":"2005","unstructured":"Karimi B, Ghoreishi-Nezhad M, Clark JH. Org Lett, Selective oxidation of sulfides to sulfoxides using 30% hydrogen peroxide catalyzed with a recoverable silica-based tungstate interphase catalyst.,, 2005, 17,, 625-628,","journal-title":"Org Lett"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.catcom.2009.07.009","volume":"10","author":"Jeyakumar K.","year":"2009","unstructured":"Jeyakumar K, Chakravarthy RD, Chand DK. Catal Commun, Simple and efficient method for the oxidation of sulfides to sulfones using hydrogen peroxide and a Mo(VI) based catalyst.,, 2009, 10,, 1948-1951,","journal-title":"Catal Commun"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0040-4039(01)90298-9","volume":"22","author":"Trost B.M.","year":"1981","unstructured":"Trost BM, Curran DP. Tetrahedron Lett, Chemoselective oxidation of sulfides to sulfones with potassium hydrogen persulfate.,, 1981, 22,, 1287-1290,","journal-title":"Tetrahedron Lett"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejmech.2012.09.004","volume":"59","author":"Konduru N.K.","year":"2013","unstructured":"Konduru NK, Dey S, Sajid M, Owais M, Ahmed N. Eur J Med Chem, Synthesis and antibacterial and antifungal evaluation of some chalcone based sulfones and bisulfones.,, 2013, 59,, 23-30,","journal-title":"Eur J Med Chem"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1021\/jo030031n","volume":"68","author":"Xu L.","year":"2003","unstructured":"Xu L, Cheng J, Trudell ML. J Org Chem, Chromium(VI) oxide catalyzed oxidation of sulfides to sulfones with periodic acid.,, 2003, 68,, 5388-5391,","journal-title":"J Org Chem"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1016\/j.tetlet.2006.03.181","volume":"47","author":"Suryakiran N.","year":"2006","unstructured":"Suryakiran N. Tetrahedron Lett, Srikanth, Reddy T.; Ashalatha, K.; Lakshman, M.; Venkateswarlu, Y. Facile polyethylene glycol (PEG-400) promoted synthesis of \u03b2-ketosulfones.,, 2006, 47,, 3853-3856,","journal-title":"Tetrahedron Lett"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1021\/acs.orglett.5b00015","volume":"17","author":"Chen C.C.","year":"2015","unstructured":"Chen CC, Waser J. Org Lett, One-pot, three-component arylalkynyl sulfone synthesis.,, 2015, 17,, 736-739,","journal-title":"Org Lett"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bmc.2014.11.038","volume":"23","author":"Staniszewska M.","year":"2015","unstructured":"Staniszewska M, Bondaryk M, Ochal Z. Bioorg Med Chem, New synthetic sulfone derivatives inhibit growth, adhesion and the leucine arylamidase APE2 gene expression of Candida albicans in vitro.,, 2015, 23,, 314-321,","journal-title":"Bioorg Med Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/ol303248h","volume":"15","author":"Umerski N.","year":"2013","unstructured":"Umerski N, Manolikakes G. Org Lett, Metal-free synthesis of diaryl sulfones from arylsulfinic acid salts and diaryliodonium salts.,, 2013, 15,, 188-191,","journal-title":"Org Lett"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"10927","DOI":"10.1016\/S0040-4020(98)00410-4","volume":"54","author":"Zhdankin V.V.","year":"1998","unstructured":"Zhdankin VV, Stang PJ. Tetrahedron, Alkyliodonium salts in organic synthesis.,, 1998, 54,, 10927-10966,","journal-title":"Tetrahedron"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1039\/C4OB00556B","volume":"12","author":"Hamnett D.J.","year":"2014","unstructured":"Hamnett DJ, Moran WJ. Org Biomol Chem, Improving alkynyl(aryl)iodonium salts: 2-anisyl as superior aryl group.,, 2014, 12,, 4156-4162,","journal-title":"Org Biomol Chem"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.tetlet.2006.11.129","volume":"48","author":"Suryakiran N.","year":"2007","unstructured":"Suryakiran N, Prabhakar P, Srikanth Reddy T, Chinni Mahesh K, Rajesh K, Venkateswarlu Y. Tetrahedron Lett, Chemoselective mono halogenation of \u03b2-keto-sulfones using potassium halide and hydrogen peroxide; synthesis of halomethyl sulfones and dihalomethyl sulfones.,, 2007, 48,, 877-881,","journal-title":"Tetrahedron Lett"},{"key":"ref=55","first-page":"215","volume":"49","author":"Ochal Z.","year":"2005","unstructured":"Ochal Z, Kami\u0144ski R. Pol J Appl Chem, Transformations of bromodichloromethyl-4-chlorophenyl sulfone into New compounds with potential pesticidal activity.,, 2005, 49,, 215-225,","journal-title":"Pol J Appl Chem"},{"key":"ref=56","author":"Ochal Z.","year":"","unstructured":"Ochal Z, Mizerski A, Gajadhur A, Ejmocki Z. PL Pat, Benzimidazole derivatives substituted fluoro-, difluoro- and trifluorometyhlsulfonyl group.,, , 49,, 215-,202745 B1, July 31, 2009.","journal-title":"PL Pat"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.3390\/molecules16119129","volume":"16","author":"Xu W.","year":"2011","unstructured":"Xu W, He J, He M, Han F, Chen X, Pan Z, Wang J, Tong M. Molecules, Synthesis and antifungal activity of novel sulfone derivatives containing 1,3,4-oxydiazole moieties.,, 2011, 16,, 9129-9141,","journal-title":"Molecules"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2174\/1573406411309080015","volume":"9","author":"Ochal Z.","year":"2013","unstructured":"Ochal Z, Bretner M, Wolinowska R, Tyski S. Med Chem, Synthesis and in vitro antibacterial activity of 5-halogenomethylsulfonyl-benzoimidazole and benzotriazole derivatives.,, 2013, 9,, 1129-1136,","journal-title":"Med Chem"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/j.bmc.2007.04.014","volume":"15","author":"Chen C.J.","year":"2007","unstructured":"Chen CJ, Song BA, Yang S, Xu GF, Bhadury PS, Jin LH, Hu DY, Li QZ, Liu F, Xue W, Lu P, Chen Z. Bioorg Med Chem, Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives.,, 2007, 15,, 3981-3989,","journal-title":"Bioorg Med Chem"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejmech.2006.12.015","volume":"42","author":"Curti C.","year":"2007","unstructured":"Curti C, Laget M, Carle AO, Gellis A, Vanelle P. Eur J Med Chem, Rapid synthesis of sulfone derivatives as potential anti-infectious agents.,, 2007, 42,, 880-884,","journal-title":"Eur J Med Chem"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3839\/jksabc.2009.006","volume":"52","author":"Kumar A.B.V.K.","year":"2009","unstructured":"Kumar ABVK, Rao KSVK, Chandra MS, Subha MCS, Choi YL. J Korean Soc Appl Biol Chem, Synthesis and antimicrobial evaluation of sulfides, sulfoxides, and sulfones.,, 2009, 52,, 34-39,","journal-title":"J Korean Soc Appl Biol Chem"},{"key":"ref=62","first-page":"208","volume":"53B","author":"Kumar L.V.","year":"2014","unstructured":"Kumar LV, Naik PJ, Naveen M, Chandrasekhar T, Reddy AB, Penchalaiah N, Swamy GN. Indian J Chem, Synthesis and biological evaluation of some new 2,5-disubstituted 1,3,4-oxadiazoles from 3-(arylsulfonyl) propanehydrazides.,, 2014, 53B,, 208-211,","journal-title":"Indian J Chem"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3762\/bjoc.8.27","volume":"8","author":"Borys K.M.","year":"2012","unstructured":"Borys KM, Korzy\u0144ski MD, Ochal Z. Beilstein J Org Chem, Derivatives of phenyl tribromomethyl sulfone as novel compounds with potential pesticidal activity.,, 2012, 8,, 259-265,","journal-title":"Beilstein J Org Chem"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.tetlet.2013.12.012","volume":"55","author":"Korzy\u0144ski M.D.","year":"2014","unstructured":"Korzy\u0144ski MD, Borys KM, Bia\u0142ek J, Ochal Z. Tetrahedron Lett, A novel method for the synthesis of aryl trihalomethyl sulfones and their derivatization: the search for new sulfone fungicides.,, 2014, 55,, 745-748,","journal-title":"Tetrahedron Lett"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00044-014-1258-8","volume":"24","author":"Bondaryk M.","year":"2015","unstructured":"Bondaryk M, Ochal Z, Staniszewska M. Med Chem Res, Comparison of anti-Candida albicans activities of halogenomethylsulfonyl derivatives.,, 2015, 24,, 1799-1813,","journal-title":"Med Chem Res"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ardp.201400360","volume":"348","author":"Staniszewska M.","year":"2015","unstructured":"Staniszewska M, Bondaryk M, Ochal Z. Arch Pharm Chem Life Sci, Susceptibility of Candida albicans to new synthetic sulfone derivatives.,, 2015, 348,, 132-143,","journal-title":"Arch Pharm Chem Life Sci"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fmicb.2016.01309","volume":"7","author":"Staniszewska M.","year":"2016","unstructured":"Staniszewska M, Bondaryk M, Wieczorek M, Estrada-Mata E, Mora-Montes HM, Ochal Z. Front Microbiol, Antifungal effect of novel 2-Bromo-2-Chloro-2-(4-Chlorophenylsulfonyl)-1-Phenylethanone against Candida strains.,, 2016, 7,, 1309-,","journal-title":"Front Microbiol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2217\/fmb-2016-0141","volume":"12","author":"Staniszewska M.","year":"2017","unstructured":"Staniszewska M, Bondaryk M, Kazek M, Gliniewicz A, Braunsdorf C, Schaller M, Mora-Montes HM, Ochal Z. Future Microbiol, Effect of serine protease KEX2 on Candida albicans virulence under halogenated methyl sulfones.,, 2017, 12,, 285-306,","journal-title":"Future Microbiol"},{"key":"ref=69","author":"Staniszewska M.","year":"","unstructured":"Staniszewska M, Bondaryk M, Ochal Z. Candida spp. PL Patent Application, Method for testing adhesion of Candida spp. cells to the surface of a model of epithelial cells monolayer in vitro, method of estimation of inhibition level of Candida spp. cells adhesion to the epithelium cells and the compound to be applied in the treatment of mycosis diseases, preferably those caused by, P.408765, July 4, 2014.,","journal-title":"Candida spp PL Patent Application"},{"key":"ref=70","author":"Ochal Z.","year":"","unstructured":"Ochal Z, Staniszewska M, Bondaryk M, Borowiecki P. , , Application of halogen methyl aryl sulfones. PL Pat., P.408200, May 13, 2014.,"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/exd.12004","volume":"21","author":"Mehra T.","year":"2012","unstructured":"Mehra T, K\u00f6berle M, Braunsdorf C, Mail\u00e4nder-Sanchez D, Borelli C, Schaller M. Exp Dermatol, Alternative approaches to antifungal therapies.,, 2012, 21,, 778-782,","journal-title":"Exp Dermatol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/21505594.2015.1039885","volume":"6","author":"Cui J.","year":"2015","unstructured":"Cui J, Ren B, Tong Y, Dai H, Zhang L. Virulence, Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.,, 2015, 6,, 362-371,","journal-title":"Virulence"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"e1004936","DOI":"10.1371\/journal.ppat.1004936","volume":"11","author":"Bahn Y.S.","year":"2015","unstructured":"Bahn YS. PLoS Pathog, Exploiting fungal virulence-regulating transcription factors as novel antifungal drug targets.,, 2015, 11,, e1004936-,","journal-title":"PLoS Pathog"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","volume":"14","author":"Gauwerky K.","year":"2009","unstructured":"Gauwerky K, Borelli C, Korting HC. Drug Discov Today, Targeting virulence: A new paradigm for antifungals.,, 2009, 14,, 214-222,","journal-title":"Drug Discov Today"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1128\/AAC.00726-15","volume":"59","author":"Li X.","year":"2015","unstructured":"Li X, Hou Y, Yue L, Liu S, Du J, Sun S. Antimicrob Agents Chemother, Potential targets for antifungal drug discovery based on growth and virulence in Candida albicans.,, 2015, 59,, 5885-5891,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","volume":"67","author":"Naglik J.R.","year":"2003","unstructured":"Naglik JR, Challacombe SJ, Hube B. Microbiol Mol Biol Rev, Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.,, 2003, 67,, 400-428,","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1096\/fj.12-214353","volume":"27","author":"Wu H.","year":"2013","unstructured":"Wu H, Downs D, Ghosh K, Ghosh AK, Staib P, Monod M, Tang J. FASEB J, Candida albicans secreted aspartic proteases 4\u20136 induce apoptosis of epithelial cells by a novel Trojan horse mechanism.,, 2013, 27,, 2132-2144,","journal-title":"FASEB J"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1074\/jbc.M509297200","volume":"281","author":"Albrecht A.","year":"2006","unstructured":"Albrecht A, Felk AA, Pichova I, Naglik JR, Schaller M, de Groot P, MacCallum D, Odds FC, Sch\u00e4fer W, Klis F. J Biol Chem, Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions.,, 2006, 281,, 688-694,","journal-title":"J Biol Chem"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1574-6968.12049","volume":"338","author":"Sorgo A.G.","year":"2013","unstructured":"Sorgo AG, Heilmann CJ, Brul S, de Koster CG, Klis FM. FEMS Microbiol Lett, Beyong the wall: Candida albicans secret(e)s to survive.,, 2013, 338,, 10-17,","journal-title":"FEMS Microbiol Lett"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1462-5822.2004.00439.x","volume":"6","author":"Naglik J.","year":"2004","unstructured":"Naglik J, Albrecht A, Bader O, Hube B. Cell Microbiol, Candida albicans proteinases and host\/pathogen interactions.,, 2004, 6,, 915-928,","journal-title":"Cell Microbiol"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s11274-014-1676-2","volume":"30","author":"Bondaryk M.","year":"2014","unstructured":"Bondaryk M, Ochal Z, Staniszewska M. World J Microbiol Biotechnol, Sulfone derivatives reduce growth, adhesion and aspartic protease SAP2 gene expression.,, 2014, 30,, 2511-2521,","journal-title":"World J Microbiol Biotechnol"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/jof3030032","volume":"3","author":"Staniszewska M.","year":"2017","unstructured":"Staniszewska M, Bondaryk M, Ochal Z. J Fungi, Role of virulence determinants in Candida albicans\u2019 resistance to novel 2-bromo-2-chloro-2-(4-chlorophenylsulfonyl)-1-phenylethanone.,, 2017, 3,, 32-,","journal-title":"J Fungi"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"28954","DOI":"10.1074\/jbc.272.46.28954","volume":"272","author":"Newport G.","year":"1997","unstructured":"Newport G, Agabian N. J Biol Chem, KEX2 influences Candida albicans proteinase secretion and hyphae formation.,, 1997, 272,, 28954-28961,","journal-title":"J Biol Chem"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"e75347","DOI":"10.1371\/journal.pone.0075347","volume":"8","author":"Yang S.","year":"2013","unstructured":"Yang S, Kuang Y, Li H, Liu Y, Hui X, Li P, Jiang Z, Zhou Y, Wang Y, Xu A, Li S, Liu P, Wu D. PLoS One, Enhanced production of recombinant secretory proteins in Pichia pastoris by optimizing Kex2 P1\u2032 site.,, 2013, 8,, e75347-,","journal-title":"PLoS One"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1365-2958.2001.02614.x","volume":"41","author":"Bader O.","year":"2001","unstructured":"Bader O, Schaller M, Klein S, Kukula J, Haack K, M\u00fchlschlegel F, Korting HC, Sch\u00e4fer W, Hube B. Mol Microbiol, The KEX2 gene of Candida glabrata is required for cell surface integrity.,, 2001, 41,, 1431-1444,","journal-title":"Mol Microbiol"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1074\/jbc.M209713200","volume":"278","author":"Newport G.","year":"2003","unstructured":"Newport G, Kuo A, Flattery A, Gill C, Blake JJ, Kurtz MB, Abruzzo GK, Agabian N. J Biol Chem, Inactivation of Kex2p diminishes the virulence of Candida albicans.,, 2003, 278,, 1713-1720,","journal-title":"J Biol Chem"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1515\/chempap-2016-0072","volume":"70","author":"Bondaryk M.","year":"2016","unstructured":"Bondaryk M, Grabowska-Jadach I, Ochal Z, Sygitowicz G, Staniszewska M. Chem Pap, Possible role of hydrolytic enzymes (Sap, Kex2) in Candida albicans response to aromatic compounds bearing a sulfone moiety.,, 2016, 70,, 1336-1350,","journal-title":"Chem Pap"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/EC.05030-11","volume":"10","author":"Shareck J.","year":"2011","unstructured":"Shareck J, Belhumeur P. Eukaryot Cell, Modulation of morphogenesis in Candida albicans by various small molecules.,, 2011, 10,, 1004-1012,","journal-title":"Eukaryot Cell"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","volume":"15","author":"Mayer F.L.","year":"2013","unstructured":"Mayer FL, Wilson D, Hube B. Virulence, Candida albicans pathogenicity mechanisms.,, 2013, 15,, 119-128,","journal-title":"Virulence"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","volume":"90","author":"Lo H.J.","year":"1997","unstructured":"Lo HJ, K\u00f6hler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Cell, Nonfilamentous C. albicans mutants are avirulent.,, 1997, 90,, 939-949,","journal-title":"Cell"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/IAI.01417-13","volume":"82","author":"Peters B.M.","year":"2014","unstructured":"Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL, Noverr MC. Infect Immun, Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis.,, 2014, 82,, 532-543,","journal-title":"Infect Immun"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1517\/17460441.2013.807245","volume":"8","author":"Pierce C.G.","year":"2013","unstructured":"Pierce CG, Lopez-Ribot JL. Expert Opin Drug Discov, Candidiasis drug discovery and development: New approaches targeting virulence for discovering and identifying new drugs.,, 2013, 8,, 1117-1126,","journal-title":"Expert Opin Drug Discov"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1534\/g3.115.017566","volume":"5","author":"Mancera E.","year":"2015","unstructured":"Mancera E, Porman AM, Cuomo CA, Bennett RJ, Johnson AD. G3 (Bethesda), Finding a missing gene: EFG1 regulates morphogenesis in Candida tropicalis.,, 2015, 5,, 849-856,","journal-title":"G3 (Bethesda)"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1099\/jmm.0.041020-0","volume":"61","author":"Bink A.","year":"2012","unstructured":"Bink A, Govaert G, Vandenbosch D, Kucharikov\u00e1 S, Coenye T, Nelis H, Van Dijck P, Cammue BP, Thevissen K. J Med Microbiol, Transcription factor Efg1 contributes to the tolerance of Candida albicans biofilms against antifungal agents in vitro and in vivo.,, 2012, 61,, 813-189,","journal-title":"J Med Microbiol"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1078\/1438-4221-00215","volume":"292","author":"Liu H.","year":"2002","unstructured":"Liu H. Int J Med Microbiol, Co-regulation of pathogenesis with dimorphism and phenotypic switching in Candida albicans, a commensal and a pathogen.,, 2002, 292,, 299-311,","journal-title":"Int J Med Microbiol"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","volume":"148","author":"Nobile C.J.","year":"2012","unstructured":"Nobile CJ, Fox EP, Nett JE, Sorrels TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. Cell, A recently evolved transcriptional network controls biofilm development in Candida albicans.,, 2012, 148,, 126-138,","journal-title":"Cell"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/EC.05206-11","volume":"11","author":"Zavrel M.","year":"2012","unstructured":"Zavrel M, Majer O, Kuchler K, Rupp S. Eukaryot Cell, Transcription factor Efg1 shows a haploinsufficiency phenotype in modulating the cell wall architecture and immunogenicity of Candida albicans.,, 2012, 11,, 129-140,","journal-title":"Eukaryot Cell"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2180-14-182","volume":"14","author":"Sherry L.","year":"2014","unstructured":"Sherry L, Rajendran R, Lappin DF, Borghi E, Perdoni F, Falleni M, Tosi D, Smith K, Williams C, Jones B, Nile CJ, Ramage G. BMC Microbiol, Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.,, 2014, 14,, 182-,","journal-title":"BMC Microbiol"},{"key":"ref=99","first-page":"e23","volume":"30","author":"dos Santos J.D.","year":"","unstructured":"dos Santos JD, Piva E, Vilela SF, Jorge AO, Junqueira JC. Braz Oral Res, Mixed biofilms formed by C. albicans and non-albicans species: A study of microbial interactions.,, , 30,, e23-,","journal-title":"Braz Oral Res"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","volume":"69","author":"Nobile C.J.","year":"2016","unstructured":"Nobile CJ, Johnson AD. Annu Rev Microbiol, Candida albicans biofilms and human disease.,, 2016, 69,, 71-92,","journal-title":"Annu Rev Microbiol"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"11660","DOI":"10.3390\/molecules200711660","volume":"20","author":"Shi L.","year":"2015","unstructured":"Shi L, Li P, Wang W, Gao M, Wu Z, Song X, Hu D. Molecules, Antibacterial activity and mechanism of action of sulfone derivatives containing 1,3,4-oxadiazole moieties on rice bacterial leaf blight.,, 2015, 20,, 11660-11675,","journal-title":"Molecules"},{"key":"ref=102","first-page":"1694","volume":"7","author":"Mora-Montes H.M.","year":"2016","unstructured":"Mora-Montes HM, Gacser A. Front Microbiol, Editorial: Recent advances in the study of the host-fungus interaction.,, 2016, 7,, 1694-,","journal-title":"Front Microbiol"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"23575","DOI":"10.1038\/srep23575","volume":"6","author":"Haque F.","year":"2016","unstructured":"Haque F, Alfatah M, Ganesan K, Bhattacharyya MS. Sci Rep, Inhibitory effect of sophorolipid on Candida albicans biofilm formation and hyphal growth.,, 2016, 6,, 23575-,","journal-title":"Sci Rep"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/j.1439-0507.2011.02156.x","volume":"55","author":"Rajeshkumar R.","year":"2012","unstructured":"Rajeshkumar R, Sundararaman M. Mycoses, Emergence of Candida spp. And exploration of natural bioactive molecules for anticandidal therapy \u2013 status quo.,, 2012, 55,, e60-e73,","journal-title":"Mycoses"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02713680590968637","volume":"30","author":"Gordon Y.J.","year":"2005","unstructured":"Gordon YJ, Romanowski EG, McDermott AM. Curr Eye Res, A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs.,, 2005, 30,, 505-515,","journal-title":"Curr Eye Res"},{"key":"ref=106","first-page":"154357","author":"Ghabbour H.A.","year":"2014","unstructured":"Ghabbour HA, Qabeel MM, Eldehna WM, Al-Dhfyan A, Abdel-Aziz H. J Chem, Design, synthesis, and molecular docking of 1-(1-(4-chlorophenyl)-2-(phenylsulfonyl)ethylidene)-2-phenylhydrazine as potent nonazole anticandidal agent.,, 2014, 30,, 154357-,","journal-title":"J Chem"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.3390\/molecules21010114","volume":"21","author":"Fares M.","year":"2016","unstructured":"Fares M, Said MA, Alsherbiny MA, Eladwy RA, Almahli H, Abdel-Aziz MM, Ghabbour HA, Eldehna WM, Abdel-Aziz HA. Molecules, Synthesis, biological evaluation and molecular docking of certain sulfones as potential nonazole antifungal agents.,, 2016, 21,, E114-,","journal-title":"Molecules"},{"key":"ref=108","first-page":"e00601","volume":"85","author":"Hasim S.","year":"2016","unstructured":"Hasim S, Allison DP, Retterer ST, Hopke A. Infect Immun, \u03b2-(1,3)-glucan unmasking in some Candida albicans mutants correlates with increases in cell wall surface roughness and decreases in cell wall elasticity.,, 2016, 85,, e00601-e00616,","journal-title":"Infect Immun"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1128\/IAI.01612-14","volume":"82","author":"Davis S.E.","year":"2014","unstructured":"Davis SE, Hopke A. Infect Immun, Minkin, Jr.; S.C. Montedonico, A.E.; Wheeler, R.T.; Reynolds, TB. Masking of \u03b2(1-3)-glucan in the cell wall of Candida albicans from detection by innate immune cells depends on phosphatidylserine.,, 2014, 82,, 4405-4413,","journal-title":"Infect Immun"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1021\/nn304116f","volume":"6","author":"El Kirat Chatel S.","year":"2012","unstructured":"El Kirat Chatel S, Dufrene YF. ACS Nano, Nanoscale imaging of the Candida-macrophage interaction using correlated fluorescence-atomic force microscopy.,, 2012, 6,, 10792-10799,","journal-title":"ACS Nano"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.00105-13","volume":"57","author":"Formosa C.","year":"2013","unstructured":"Formosa C, Schiavone M, Martin-Yken H, Francois JM, Duval RE, Dague E. Antimicrob Agents Chemother, Nanoscale effects of caspofungin against two yeast species, Saccharomyces cerevisiae and Candida albicans.,, 2013, 57,, 3498-3506,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nprot.2015.004","volume":"10","author":"Formosa C.","year":"2015","unstructured":"Formosa C, Pillet F, Schiavone M, Duval RE, Ressier L, Dague E. Nat Protoc, Generation of living cells arrays for atomic force microscopy.,, 2015, 10,, 199-204,","journal-title":"Nat Protoc"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mito.2014.06.006","volume":"19","author":"Repnik U.","year":"2014","unstructured":"Repnik U, \u010cesen MH, Turk B. Mitochondrion, Lysosomal membrane permeabilization in cell death: Concepts and challenges.,, 2014, 19,, 49-57,","journal-title":"Mitochondrion"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1242\/jeb.088930","volume":"217","author":"Brown A.J.P.","year":"2014","unstructured":"Brown AJP, Budge S, Koloriti D, Tillmann A, Jacobsen MD, Yin Z, Ene IV, Bohovych I, Sandai D, Kastora S. J Exp Biol, Stress adaptation in a pathogenic fungus.,, 2014, 217,, 144-155,","journal-title":"J Exp Biol"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/165592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T21:59:39Z","timestamp":1755727179000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/165592\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557518666180924121209","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-03-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}